Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5612211

Title:Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
Inventors:Wilson, Elaine L.; New York, NY, USA
Gabrilove, Janice; New York, NY, USA
Summary:Described herein is a method for the in vitro proliferation of hematopoietic progenitor cells in a medium containing a fibroblast growth factor. The invention relates to the use of such fibroblast growth factors in vivo, in situ and in vitro to stimulate stem cells, hematopoiesis, the immune system, transplant donor cells, culture and engraftment. Therapeutic applications to a variety of diseases are included.
Abstract:Fibroblast growth factors are used in vivo, in situ and in vitro to stimulate stem cells, hemopoiesis, the immune system, transplant donor cells, culture and/or engraftment, wherein the use of fibroblast growth factors is disclosed for the stimulation of stem cells or hemopoietic cells, supporting cells and their progeny, in vitro, in situ and in vivo, as well as corresponding engrafting sites in vivo.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5612211
Application Number:US1993000076875
Date Filed:15/06/1993
Date Published:18/03/1997
Assignee:New York University, New York, NY, USA Sloan-Kettering Institute For Cancer Research, New York, NY, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/23/2021